Ongoing
Integrating cognitive-behavioural therapy for social anxiety disorder with HIV risk reduction counselling for HIV-negative gay and bisexual men who are at high risk for HIV
Learn MoreOngoing
HIV Prevention for Gay, Bisexual, and other Men Who Have Sex with Men
Learn MoreOngoing
A randomized controlled, open-label trial examining the efficacy, safety, and tolerability of ablative therapies for high-grade anal dysplasia versus observation alone in HIV-positive men who have sex with men (MSM) – part of HPV-SAVE study.
Learn MoreOngoing
Development and validation of an anal cancer screening algorithm in HIV-positive men who have sex with men (MSM) – part of HPV-SAVE study.
Learn MoreCompleted
Motivational Interviewing in Conjunction with Rapid HIV Testing
Learn MoreReporting
Reporting
A small group intervention to reduce HIV sexual transmission risk behaviour among HIV-positive men who have sex with men: Gay Positive Sex (GPS)
Learn MoreCompleted
On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
Learn MoreReporting
HIV prevention for gay and bisexual men via reduction of social anxiety and substance use in sexual situations
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
